Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer Mar 08, 2010 Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 30th Annual Cowen and Company Healthcare Conference in Boston Mar 02, 2010 Nektar Therapeutics Reports Year-End 2009 Financial Results Mar 02, 2010 Nektar to Announce Year-End 2009 Financial Results on Tuesday, March 2, 2010, After Close of U.S.-Based Financial Markets Feb 23, 2010 Nektar Therapeutics Appoints R. Scott Greer to Board of Directors Feb 02, 2010 Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer Jan 12, 2010 Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer Jan 06, 2010 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 06, 2010 Dennis Winger Joins Nektar Therapeutics' Board of Directors Dec 14, 2009 Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer Nov 30, 2009 Pagination First page « first Previous page ‹ previous … Page 36 Page 37 Page 38 Page 39 Current page 40 Page 41 Page 42 Page 43 Page 44 … Next page next › Last page last »